Revolutionizing TB Diagnosis with Rapid, Accurate Detection and AMR Profiling
Empowering Healthcare to Save Lives Worldwide
The world's largest lung health conference, the World Conference on Lung Health, will take place at the Bella Center in Copenhagen, Denmark from 18-21 November 2025.
We are excited to announce that we will be participating in the World Conference on Lung Health 2025 organized by the International Union Against Tuberculosis and Lung Disease (The Union), the world’s largest gathering dedicated to lung health and tuberculosis (TB). The conference will be held at the Bella Center, Copenhagen, Denmark, from 18–21 November 2025.
Our team — Jan Buch Andersen, Dev Chandran , and Gayathri Ramasubban — will be present to engage with key stakeholders, collaborators, and global leaders in the TB arena.
If you are interested to collaborate, kindly write or reach out to us-
Jan Buch Andersen Dev Chandran PhD Gayathri Ramasubban
jan.andersen@empediagnostics.com dev@empediagnostics.com gayathri@empediagnostics.com
+46 70 919 92 49 +91 9849189699 +91 9841546666
You can also write to us at-
https://lnkd.in/drvxC6eT/
We look forward to sharing insights, fostering collaborations, and contributing to the collective effort toward ending TB through innovation in molecular diagnostics.
Stay tuned for updates from Copenhagen!
EMPE Diagnostics AB
Founded in 2015, EMPE Diagnostics AB is a pioneering healthcare company based on innovations from the prestigious Karolinska Institutet in Sweden. We are dedicated to addressing the global tuberculosis (TB) crisis by developing rapid, reliable, and cost-effective diagnostic solutions. Our mission is to combat TB and antimicrobial resistance (AMR) by providing tests that not only detect TB infections but also simultaneously profile antibiotic resistance, ensuring patients receive the correct treatment from the outset.
With a focus on India, where over 2.7 million new TB infections occur annually, EMPE Diagnostics is playing a pivotal role in the fight against TB. Our innovative products have gained full regulatory approval, and we are fully equipped to support global demand through our manufacturing facility in Hyderabad, India. We are proud to be ISO 13485 certified and to meet the "Made in India" criteria, which is crucial for government contracts.
Our Expertise
At the forefront of medical innovation, we specialize in developing cutting-edge solutions for rapid and accurate Tuberculosis (TB) diagnosis and antimicrobial resistance (AMR) profiling. Our advanced molecular diagnostics leverage state-of-the-art technology to deliver precise results in record time, enabling healthcare professionals to make critical treatment decisions with confidence. With a deep understanding of TB biology, global health challenges, and diagnostic needs, we are committed to transforming TB care by enhancing early detection and personalized treatment plans, driving better patient outcomes, and combating the growing threat of drug-resistant TB.
